These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 19258280

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Suresh M, Nithya N, Jayasree PR, Vimal KP, Manish Kumar PR.
    World J Microbiol Biotechnol; 2018 May 30; 34(6):83. PubMed ID: 29846800
    [Abstract] [Full Text] [Related]

  • 4. MexXY RND pump of Pseudomonas aeruginosa PA7 effluxes bi-anionic β-lactams carbenicillin and sulbenicillin when it partners with the outer membrane factor OprA but not with OprM.
    Singh M, Sykes EME, Li Y, Kumar A.
    Microbiology (Reading); 2020 Nov 30; 166(11):1095-1106. PubMed ID: 32909933
    [Abstract] [Full Text] [Related]

  • 5. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ, Black JA, Lister PD, Hanson ND.
    J Antimicrob Chemother; 2009 Aug 30; 64(2):294-300. PubMed ID: 19468029
    [Abstract] [Full Text] [Related]

  • 6. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H, Sáenz Y, Nichols WW, Tulkens PM, Van Bambeke F.
    Int J Antimicrob Agents; 2018 Nov 30; 52(5):697-701. PubMed ID: 30081137
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR, Rajabpour M, Yousefi Mashouf R, Alikhani MY, Mousavi SM.
    Arch Iran Med; 2015 Feb 30; 18(2):102-8. PubMed ID: 25644798
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M, Hojabri Z, Mahdian R, Nahaei MR, Rahmati M, Hojabri T, Pirzadeh T, Pajand O.
    Infect Genet Evol; 2014 Jun 30; 24():187-92. PubMed ID: 24694825
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains.
    Zahedi Bialvaei A, Rahbar M, Hamidi-Farahani R, Asgari A, Esmailkhani A, Mardani Dashti Y, Soleiman-Meigooni S.
    Microb Pathog; 2021 Apr 30; 153():104789. PubMed ID: 33556480
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic.
    Chalhoub H, Pletzer D, Weingart H, Braun Y, Tunney MM, Elborn JS, Rodriguez-Villalobos H, Plésiat P, Kahl BC, Denis O, Winterhalter M, Tulkens PM, Van Bambeke F.
    Sci Rep; 2017 Jan 16; 7():40208. PubMed ID: 28091521
    [Abstract] [Full Text] [Related]

  • 15. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.
    Hocquet D, Bertrand X, Köhler T, Talon D, Plésiat P.
    Antimicrob Agents Chemother; 2003 Jun 16; 47(6):1887-94. PubMed ID: 12760863
    [Abstract] [Full Text] [Related]

  • 16. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
    Dean CR, Visalli MA, Projan SJ, Sum PE, Bradford PA.
    Antimicrob Agents Chemother; 2003 Mar 16; 47(3):972-8. PubMed ID: 12604529
    [Abstract] [Full Text] [Related]

  • 17. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T, Srimanote P, Chusri S, Yingyongnarongkul BE, Suaisom C, Tipmanee V, Voravuthikunchai SP.
    BMC Complement Altern Med; 2017 Aug 14; 17(1):405. PubMed ID: 28806947
    [Abstract] [Full Text] [Related]

  • 18. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.
    Muller C, Plésiat P, Jeannot K.
    Antimicrob Agents Chemother; 2011 Mar 14; 55(3):1211-21. PubMed ID: 21149619
    [Abstract] [Full Text] [Related]

  • 19. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
    Poole K, Gilmour C, Farha MA, Parkins MD, Klinoski R, Brown ED.
    J Antimicrob Chemother; 2018 May 01; 73(5):1247-1255. PubMed ID: 29420743
    [Abstract] [Full Text] [Related]

  • 20. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Vogne C, Aires JR, Bailly C, Hocquet D, Plésiat P.
    Antimicrob Agents Chemother; 2004 May 01; 48(5):1676-80. PubMed ID: 15105120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.